drugset / Trial / NCT04255420

SPG Blocks for Headaches

NCT04255420

Non-randomizedParallel-groupOpen-labelTreatment

Summary

This will be a single-center, open-label clinical trial comparing sphenopalatine ganglion blocks to standard intravenous therapy for patients who come to the emergency department for a headache.

Timeline

Start
2020-02-21
Primary completion
2021-05-30
Completion
2021-06-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Diphenhydramine Unknown 50 mg Intravenous
Subject Prochlorperazine Small molecule 10 mg Intravenous

Indications